This HTML5 document contains 42 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q80483198
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel artikull shkencor i botuar më 01 janar 2004 im Jahr 2004 veröffentlichter wissenschaftlicher Artikel наукова стаття, опублікована в січні 2004 scientific article published on 01 January 2004 artículu científicu espublizáu en xineru de 2004
p:P577
wds:Q80483198-96C6F4DD-65EF-4697-94A8-2D7A190ABEC5
wdt:P577
2004-01-01T00:00:00Z
p:P2093
wds:Q80483198-7824AD61-FC2C-4FC3-94FA-0EC133ABAF37
wdt:P2093
Anna Csiszar
rdfs:label
Synergistic effects of vascular IL-17 and TNFalpha may promote coronary artery disease Synergistic effects of vascular IL-17 and TNFalpha may promote coronary artery disease Synergistic effects of vascular IL-17 and TNFalpha may promote coronary artery disease
skos:prefLabel
Synergistic effects of vascular IL-17 and TNFalpha may promote coronary artery disease Synergistic effects of vascular IL-17 and TNFalpha may promote coronary artery disease Synergistic effects of vascular IL-17 and TNFalpha may promote coronary artery disease
schema:name
Synergistic effects of vascular IL-17 and TNFalpha may promote coronary artery disease Synergistic effects of vascular IL-17 and TNFalpha may promote coronary artery disease Synergistic effects of vascular IL-17 and TNFalpha may promote coronary artery disease
p:P50
wds:Q80483198-8D60FF96-84F4-40AB-82F4-8404CE9A0064
wdt:P50
wd:Q60324829
p:P1476
wds:Q80483198-12C4E3C3-805B-43AF-B86F-13AC7A91B3EA
wdt:P1476
Synergistic effects of vascular IL-17 and TNFalpha may promote coronary artery disease
p:P304
wds:Q80483198-3A84254A-15D9-4029-BD99-8C4BDC83B29C
wdt:P304
696-698
p:P31
wds:Q80483198-061BD57B-279B-4B65-ADDE-9B8A0D5A560B
wdt:P31
wd:Q13442814
p:P921
wds:Q80483198-014ECAF5-5427-47A8-B763-5025F47C043B
wdt:P921
wd:Q844935
p:P698
wds:Q80483198-B69A725E-FAED-4BCA-A4A2-D8D282D738B4
wdtn:P698
n11:15325020
wdt:P698
15325020
p:P1433
wds:Q80483198-FD495D9D-EE01-4C09-A4A0-354E19659930
wdt:P1433
wd:Q5558534
p:P433
wds:Q80483198-C93567FA-77CF-4E52-A677-9A7807FB1002
p:P478
wds:Q80483198-4A8875A0-721F-4FA0-B713-FACD0471C145
wdt:P433
4
wdt:P478
63
p:P356
wds:Q80483198-C65CB68B-8C5F-44E9-AC99-B199767BF2B7
wdtn:P356
n12:J.MEHY.2004.03.009
wdt:P356
10.1016/J.MEHY.2004.03.009